Le Lézard
Classified in: Health
Subject: SVY

United States Patient Monitoring Devices Market Analysis and Forecast to 2026 - US Market Forecast to Reach $13,110.7 Million by 2026


DUBLIN, Aug. 12, 2020 /PRNewswire/ -- The "U.S. Patient Monitoring Devices Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The U.S. Patient monitoring market is expected to reach $13,110.7 million by 2026 growing at low single digit CAGR.

The increase in the rate of surgeries and diseased population requires continuous monitoring, increasing demand for portable and remote patient monitoring and increasing funding and investment in patient monitoring are driving the market growth. However, the high cost of patient monitoring devices, stringent regulatory approvals for products, patient safety and inaccuracy concerns associated with patient monitoring devices and increased product recalls are restraining the market growth.

The U.S. patient monitoring market is segmented based on device type, portability and end-users. The market by devices type is segmented into neuromonitoring, hemodynamic monitoring, blood glucose monitoring, cardiac monitoring, fetal & neonatal care monitoring, respiratory care monitoring, multi-parameter monitoring, temperature monitoring and remote patient monitoring.

The blood glucose monitoring sector accounted for the largest revenue of in 2019 and is expected to grow at a low single digit CAGR from 2019 to 2026. Remote patient monitoring is expected to grow at a high single digit CAGR from 2019 to 2026, due to increasing demand by patients for home healthcare and increasing connectivity of rural areas.

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

4 Patient Monitoring Devices Market, by Devices

5 Patient Monitoring Devices Market, by Portability

6 Patient Monitoring U.S. Market, by End-Users


7 Competitive Landscape


8 Major Player Profiles
8.1 Abbott Laboratories
8.2 Bio Telemetry Inc
8.3 Dexcom, Inc
8.4 Edwards Lifesciences Corporation.
8.5 GE Healthcare
8.6 Hill-Rom Holdings, Inc.
8.7 Irhythm Technologies, Inc.
8.8 Koninklijke Philips N.V.
8.9 Masimo Corporation
8.10 Medtronic, Plc
8.11 Natus Medical Incorporated.
8.12 Omron Corporation

For more information about this report visit https://www.researchandmarkets.com/r/jn5753

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

4 mai 2024
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

4 mai 2024
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

4 mai 2024
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: